Vernal Keratoconjunctivitis (VKC) / Spring Catarrh

Vernal Keratoconjunctivitis (VKC) / Spring Catarrh

Definition: VKC is a recurrent, bilateral, interstitial, self-limiting, allergic inflammation of the conjunctiva having a periodic seasonal incidence.

Etiopathogenesis

Found in individuals with a predisposed atopic background. Previously considered a type-I IgE-mediated hypersensitivity reaction to pollen. Now believed that pathogenesis is characterized by Th2 lymphocyte alteration and that the exaggerated IgE response to common allergens is a secondary event.

Predisposing factors

  • Age and sex: 4-20 years; more common in boys than girls.
  • Season: More common in summer; hence the name "spring catarrh" seems to be a misnomer. Recently labelled as 'Warm weather conjunctivitis'. Seasonal exacerbation is common, but symptoms can be year-round.
  • Climate: More prevalent in tropics, less in temperate zones, almost non-existent in cold climates.
  • Other atopic manifestations: Eczema or asthma associated in 40-75% of patients.
  • Family history: Atopy found in 40-60% of patients.

Pathology

  • Conjunctival epithelium in the papillary region contains large numbers of mast cells & eosinophils, undergoes hyperplasia, and sends downward projections into subepithelial tissue.
  • Adenoid layer shows marked cellular infiltration (mast cells, eosinophils, plasma cells, lymphocytes, histiocytes).
  • Fibrous layer shows proliferation which later undergoes hyaline changes.
  • Conjunctival vessels show proliferation, increased permeability, and vasodilation.

Note: All these changes lead to the formation of multiple papillae in the upper tarsal conjunctiva.

Clinical Features

Symptoms:
  • Marked burning and itching sensation (intolerable, accentuated in warm/humid atmosphere). Itching is more marked with palpebral form.
  • Mild photophobia & lacrimation.
  • Stringy (ropy) discharge and heaviness of lids.

Signs & Clinical Forms

1. Palpebral VKC: Usually upper tarsal conjunctiva of both eyes. Characterized by hard, flat-topped papillae arranged in a 'cobble-stone' or 'pavement stone' fashion with hyperemia. In severe cases, giant papillae (cauliflower-like) form. Associated with white ropy discharge.

Palpebral form of vernal keratoconjunctivitis
Palpebral form of vernal keratoconjunctivitis

2. Bulbar limbal VKC:

  • Dusky red triangular congestion of bulbar conjunctiva in palpebral area.
  • Limbal papillae (gelatinous, thickened confluent accumulation around limbus).
  • Presence of discrete whitish raised dots along the limbus called Horner-Tranta's spots.
Bulbar limbal VKC: Horner-Tranta's Spots

3. Mixed VKC: Combined features of both palpebral and bulbar forms.

Vernal Keratopathy

Corneal involvement is more frequent with palpebral form and includes:

  • Superior punctate epithelial keratitis: Upper cornea, caused by friction from inflamed tarsal conjunctiva. Stains with rose bengal and fluorescein.
  • Epithelial macro erosions: Coalescence of punctate lesions (Bowman's membrane intact).
  • Vernal corneal plaques: Coating of bare areas with altered exudates.
  • Ulcerative vernal keratitis (Shield ulceration): Shallow transverse ulcer in upper cornea. A serious problem prone to bacterial keratitis.
  • Subepithelial scarring: Ring scar formation.
  • Pseudogerontoxon: Develops in recurrent limbal disease (classical 'cupid's bow' outline).
Vernal Keratopathy: Shield Ulcer
Clinical Course & Differential Diagnosis:

The disease is often self-limiting and usually burns out spontaneously after 5-10 years. Needs to be differentiated from trachoma (papillary hypertrophy) and Atopic Keratoconjunctivitis (AKC).

Treatment

A. Topical anti-allergic & anti-inflammatory

  • Dual action antihistamines/mast cell stabilizers: First-line for mild/moderate cases (olopatadine 0.1%, azelastine, bepotastine 1.5%).
  • Mast cell stabilizers: Sodium cromoglycate 2% drops (3-4 times/day).
  • Topical steroids: Effective in all forms but reserved for moderate/severe/recalcitrant cases due to steroid-induced glaucoma risk. Monitor IOP. Intensive short tapering course. (Safest: loteprednol, fluorometholone).
  • Topical Immunomodulators: When steroids are ineffective or as steroid-sparing agents (Cyclosporine 0.5-1%, Tacrolimus 0.03% ointment).

B. Topical lubricating and mucolytics

  • Artificial tears: Carboxymethyl cellulose for soothing effect.
  • Acetyl cysteine (0.5%): Mucolytic properties, useful for early plaque formation.

C. Systemic therapy (Severe cases only)

  • Oral antihistaminics (for severe itching).
  • Oral steroids (short duration for advanced/non-responsive cases).

D. Treatment of large papillae

Supratarsal steroid injection
OR
Cryo-application
OR
Surgical excision (for giant papillae)

E. Supportive measures

  • Dark goggles to prevent photophobia.
  • Cold compresses and ice packs.
  • Avoid eye rubbing (causes mast cell degranulation).
  • Change of place from hot to cold area for recalcitrant cases.

F. Treatment of Vernal Keratopathy

  • Punctate epithelial keratitis: Increase steroid instillation.
  • Large vernal plaque: Superficial keratectomy excision.
  • Severe shield ulcer: Debridement, superficial keratectomy, excimer laser therapeutic keratectomy, or amniotic membrane transplantation to enhance re-epithelialization.

💬 Comments

No comments:

Post a Comment